MedOptimise is a forward-thinking startup that offers a comprehensive medicines optimization solution. The award-winning technology provided by MedOptimise has proven its capability in helping CCGs/Alliances/PCNs/Clusters and Practices to easily achieve their QIPP programs within the first quarter of the year, thanks to enhanced reporting tools and a savings generation algorithm. The system's unique high-performance business intelligence software simplifies medicines optimization QIPP project work, enabling faster savings generation and reporting to achieve targets earlier in the fiscal year. Moreover, clinical professionals can use the system to record patient review outcomes and compare them with peers, thus gaining a confidence boost and improving overall performance. With a founding year of 2014, MedOptimise operates in the Analytics and Health Care industries. The company, which is headquartered in an unspecified location, has not disclosed its last investment or the investors involved. However, the startup is led by senior experienced clinical pharmacists, ensuring a system that meets the specific needs of its users. MedOptimise provides a promising opportunity for investors looking to support innovative solutions in healthcare and analytics.
There is no investment information
No recent news or press coverage available for MedOptimise.